Stacy R Smith MD Apc

1. Pfizer Inc. $423,963 41 payments
2. Janssen Research & Development, LLC $337,793 40 payments
3. Sun Pharmaceutical Industries Inc. $239,640 78 payments
4. AbbVie, Inc. $221,440 62 payments
5. LEO Pharma AS $43,163 10 payments

1. A Phase 2B Randomized Double Blind Vehicle Controlled Parallel Group Study to Assess the Efficacy Safety Tolerability and Pharmacokinetics of Multiple Dose Levels of Pf07038124 Ointment for 12 Weeks in Participants 12 Years and Older and With Mildtomoderate Atopic Dermatitis Or Mildtosevere Plaque Psoriasis $196,949 12 payments
2. A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Plaque Psoriasis in Participants with at Least Moderate Severity Affecting Special Areas or Lower Body Surf $194,284 20 payments
3. A Phase 3 Randomized Doubleblind 52Week Placebocontrolled Multicenter Study Investigating the Efficacy Safety and Tolerability of Ritlecitinib in Adult and Adolescent Participants With Non Segmental Vitiligo $186,081 20 payments
4. A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis $138,431 18 payments
5. M15-997 $137,760 36 payments
6. Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis $77,021 39 payments
7. A Multicenter, Randomized, Double Blind, Placebo Controlled Clinical Study to Assess the Efficacy and Safety of Tildrakizumab in the Treatment of Moderate to Severe Plaque Psoriasis of the Scalp $63,161 14 payments
8. A multicenter, open Label study to assess the safety and efficacy of risankizumab for maintenance in moderate to severe plaque type psoriasis (LIMMITLESS) $60,305 20 payments
9. Efficacy and Safety of ILUMYA in the Treatment of Scalp Psoriasis $48,834 12 payments
10. Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - Ecztra 2 Eczema Tralokinumab Trial No. 2 Ecztra 2 $43,163 10 payments

1. Professional salary support $63,161 14 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.